These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 3156659
1. Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade. Neve KA, Loeschen S, Marshall JF. Brain Res; 1985 Mar 11; 329(1-2):225-31. PubMed ID: 3156659 [Abstract] [Full Text] [Related]
2. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Neve KA, Altar CA, Wong CA, Marshall JF. Brain Res; 1984 Jun 04; 302(1):9-18. PubMed ID: 6428705 [Abstract] [Full Text] [Related]
3. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade. Pich EM, Benfenati F, Farabegoli C, Fuxe K, Meller E, Aronsson M, Goldstein M, Agnati LF. Brain Res; 1987 Dec 01; 435(1-2):147-52. PubMed ID: 2962698 [Abstract] [Full Text] [Related]
4. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat. Neve KA, Marshall JF. Neurosci Lett; 1984 Apr 20; 46(1):77-83. PubMed ID: 6203067 [Abstract] [Full Text] [Related]
5. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Hamblin MW, Creese I. Life Sci; 1983 May 09; 32(19):2247-55. PubMed ID: 6133202 [Abstract] [Full Text] [Related]
6. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action. LaHoste GJ, Marshall JF. Brain Res; 1989 Nov 20; 502(2):223-32. PubMed ID: 2531015 [Abstract] [Full Text] [Related]
7. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Lévesque D, Di Paolo T. Mol Pharmacol; 1991 May 20; 39(5):659-65. PubMed ID: 1674586 [Abstract] [Full Text] [Related]
8. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis. LaHoste GJ, Marshall JF. Neuroscience; 1991 May 20; 41(2-3):473-81. PubMed ID: 1678501 [Abstract] [Full Text] [Related]
9. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study. Morissette M, Lévesque D, Di Paolo T. Mol Pharmacol; 1992 Sep 20; 42(3):480-8. PubMed ID: 1357544 [Abstract] [Full Text] [Related]
10. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. Enz A, Goldstein M, Meller E. Mol Pharmacol; 1990 Apr 20; 37(4):560-5. PubMed ID: 1970116 [Abstract] [Full Text] [Related]
11. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA. J Pharmacol Exp Ther; 1987 Jan 20; 240(1):167-76. PubMed ID: 3100767 [Abstract] [Full Text] [Related]
12. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade. Henry JM, Roth GS. Life Sci; 1984 Aug 20; 35(8):899-904. PubMed ID: 6482680 [Abstract] [Full Text] [Related]
13. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation. Dewar KM, Paquet M, Reader TA. Neurochem Int; 1997 Jun 20; 30(6):613-21. PubMed ID: 9153003 [Abstract] [Full Text] [Related]
14. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O, Biggio G. Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234 [Abstract] [Full Text] [Related]
15. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ). Kula NS, George T, Baldessarini RJ. Brain Res Dev Brain Res; 1992 Apr 24; 66(2):286-9. PubMed ID: 1535031 [Abstract] [Full Text] [Related]
16. Dopamine receptor alterations correlate with increased GABA levels in adult rat neostriatum: effects of a neonatal 6-hydroxydopamine denervation. Molina-Holgado E, Van Gelder NM, Dewar KM, Reader TA. Neurochem Int; 1995 Apr 24; 27(4-5):443-51. PubMed ID: 8845745 [Abstract] [Full Text] [Related]
17. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats. Ekman A, Eriksson E. Life Sci; 1991 Apr 24; 48(4):321-31. PubMed ID: 1824955 [Abstract] [Full Text] [Related]
18. Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours. Farabegoli C, Merlo Pich E, Cimino M, Agnati LF, Fuxe K. Acta Physiol Scand; 1988 Feb 24; 132(2):209-16. PubMed ID: 2906500 [Abstract] [Full Text] [Related]
19. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites. Kozlowski MR, Neve KA, Grisham JE, Marshall JF. Brain Res; 1983 May 16; 267(2):301-11. PubMed ID: 6409351 [Abstract] [Full Text] [Related]
20. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats. Henry JM, Joseph JA, Kochman K, Roth GS. Brain Res; 1987 Aug 25; 418(2):334-42. PubMed ID: 2960421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]